Pomanda estimates the enterprise value of NEURONOSTICS LIMITED at £121.7k based on a Turnover of £104.4k and 1.17x industry multiple (adjusted for size and gross margin).
neuronostics limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of NEURONOSTICS LIMITED at £0 based on an EBITDA of £-500.8k and a 5.52x industry multiple (adjusted for size and gross margin).
neuronostics limitedEstimated Valuation
£1.4m
Pomanda estimates the enterprise value of NEURONOSTICS LIMITED at £1.4m based on Net Assets of £730.5k and 1.93x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Neuronostics LimitedOverview
Neuronostics Limited is a live company located in bristol, BS1 6QH with a Companies House number of 11123728. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in December 2017, it's largest shareholder is
professor john terry
with a 22.7% stake. Neuronostics Limited is a young,
micro sized company, Pomanda has estimated its turnover at
£104.4k with
declining
growth in recent years.
Pomanda's financial health check has awarded Neuronostics Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
4 Strong
2 Regular
5 Weak
Size
annual sales of £104.4k, make it smaller than the average company (£4.4m)
£104.4k - Neuronostics Limited
£4.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -39%, show it is growing at a slower rate (8.3%)
-39% - Neuronostics Limited
8.3% - Industry AVG
Production
with a gross margin of 48.5%, this company has a comparable cost of product (48.5%)
48.5% - Neuronostics Limited
48.5% - Industry AVG
Profitability
an operating margin of -489% make it less profitable than the average company (1.8%)
-489% - Neuronostics Limited
1.8% - Industry AVG
Employees
with 13 employees, this is below the industry average (45)
13 - Neuronostics Limited
45 - Industry AVG
Pay Structure
on an average salary of £64k, the company has an equivalent pay structure (£64k)
£64k - Neuronostics Limited
£64k - Industry AVG
Efficiency
resulting in sales per employee of £8k, this is less efficient (£124.4k)
£8k - Neuronostics Limited
£124.4k - Industry AVG
Debtor Days
it gets paid by customers after 21 days, this is earlier than average (53 days)
21 days - Neuronostics Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 357 days, this is slower than average (40 days)
357 days - Neuronostics Limited
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Neuronostics Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 209 weeks, this is more cash available to meet short term requirements (33 weeks)
209 weeks - Neuronostics Limited
33 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.2%, this is a lower level of debt than the average (43%)
12.2% - Neuronostics Limited
43% - Industry AVG
NEURONOSTICS LIMITED financials
EXPORT
Neuronostics Limited's latest turnover from December 2024 is £104.4 thousand and the company has net assets of £730.5 thousand. According to their latest financial statements, Neuronostics Limited has 13 employees and maintains cash reserves of £386.2 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Turnover
104,388
1,084,672
463,625
311,230
410,249
263,379
Other Income Or Grants
Cost Of Sales
53,806
573,422
249,584
172,162
218,241
140,076
Gross Profit
50,582
511,251
214,041
139,068
192,008
123,304
Admin Expenses
561,065
652,143
874,881
177,114
119,361
247,209
161,650
Operating Profit
-510,483
-652,143
-363,630
36,927
19,707
-55,201
-38,346
Interest Payable
427
607
2,962
2,212
1,098
Interest Receivable
6,892
3,676
7,674
513
51
514
388
Pre-Tax Profit
-504,018
-649,074
-358,918
35,228
18,660
-54,687
-37,958
Tax
50,277
-15,452
-6,693
-3,545
Profit After Tax
-453,741
-664,526
-358,918
28,535
15,115
-54,687
-37,958
Dividends Paid
Retained Profit
-453,741
-664,526
-358,918
28,535
15,115
-54,687
-37,958
Employee Costs
831,566
709,574
703,764
551,976
236,875
289,189
227,703
Number Of Employees
13
11
11
9
4
5
4
EBITDA*
-500,767
-644,308
-355,403
44,654
22,919
-54,707
-38,264
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Tangible Assets
12,362
6,589
3,095
6,670
3,365
906
1,400
Intangible Assets
46,546
45,157
30,735
27,975
11,208
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
58,908
51,746
33,830
34,645
14,573
906
1,400
Stock & work in progress
Trade Debtors
6,175
1,361
23,481
Group Debtors
Misc Debtors
380,943
55,252
98,990
106,953
73,379
64,853
11,033
Cash
386,200
733,758
96,796
341,699
68,718
33,515
103,493
misc current assets
total current assets
773,318
789,010
195,786
450,013
142,097
98,368
138,007
total assets
832,226
840,756
229,616
484,658
156,670
99,274
139,407
Bank overdraft
1,142
Bank loan
7,200
7,201
6,960
7,151
Trade Creditors
52,766
3,597
112,552
7,928
2,220
20,448
14,022
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
35,805
61,793
19,406
12,938
195,883
171,469
8,748
total current liabilities
95,771
72,591
138,918
28,017
199,245
191,917
22,770
loans
5,965
13,166
20,608
27,633
34,858
hp & lease commitments
Accruals and Deferred Income
other liabilities
154,593
provisions
total long term liabilities
5,965
13,166
20,608
27,633
34,858
154,593
total liabilities
101,736
85,757
159,526
55,650
234,103
191,917
177,363
net assets
730,490
754,999
70,090
429,008
-77,433
-92,643
-37,956
total shareholders funds
730,490
754,999
70,090
429,008
-77,433
-92,643
-37,956
Dec 2024
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Operating Activities
Operating Profit
-510,483
-652,143
-363,630
36,927
19,707
-55,201
-38,346
Depreciation
4,121
3,925
4,317
4,484
1,970
494
82
Amortisation
5,595
3,910
3,910
3,243
1,242
Tax
50,277
-15,452
-6,693
-3,545
Stock
Debtors
331,866
-43,738
-9,324
34,935
8,526
30,339
34,514
Creditors
49,169
-108,955
104,624
5,708
-18,228
6,426
14,022
Accruals and Deferred Income
-25,988
42,387
6,468
-182,945
24,414
162,721
8,748
Deferred Taxes & Provisions
Cash flow from operations
-759,175
-682,590
-234,987
-174,211
17,034
84,101
-50,008
Investing Activities
capital expenditure
-16,878
-25,751
-7,412
-27,799
-16,879
-1,482
Change in Investments
cash flow from investments
-16,878
-25,751
-7,412
-27,799
-16,879
-1,482
Financing Activities
Bank loans
-1
241
-191
7,151
Group/Directors Accounts
Other Short Term Loans
Long term loans
-7,201
-7,442
-7,025
-7,225
34,858
Hire Purchase and Lease Commitments
other long term liabilities
-154,593
154,593
share issue
429,232
1,349,435
477,906
95
2
interest
6,465
3,069
4,712
-1,699
-1,047
514
388
cash flow from financing
428,495
1,345,303
-2,504
476,133
33,906
-154,079
154,983
cash and cash equivalents
cash
-347,558
636,962
-244,903
272,981
35,203
-69,978
103,493
overdraft
-1,142
1,142
change in cash
-347,558
636,962
-244,903
274,123
34,061
-69,978
103,493
neuronostics limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for neuronostics limited. Get real-time insights into neuronostics limited's credit score, group structure and payment trends.
Perform a competitor analysis for neuronostics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in BS1 area or any other competitors across 12 key performance metrics.
neuronostics limited Ownership
NEURONOSTICS LIMITED group structure
Neuronostics Limited has no subsidiary companies.
Ultimate parent company
NEURONOSTICS LIMITED
11123728
NEURONOSTICS LIMITED Shareholders
The largest shareholders in Neuronostics Limited include Professor John Terry and Mr Wessel Woldman.
professor john terry
22.67%
mr wessel woldman
16.35%
university of exeter
13.4%
kcp nominees ltd
9.64%
ciosif (fsesm)
8.89%
king's college london
6.23%
mnl (ascension) nominees ltd
5.87%
roderick jack
3.13%
science angle syndicate
2.38%
empirical ventures bbi nominees
2.01%
neuronostics limited directors
Neuronostics Limited currently has 6 directors.
The longest serving directors include
Mr Wessel Woldman (Dec 2017) and
Professor John Terry (Sep 2018).
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
December 2017
age
8
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
December 2024
previous names
N/A
accountant
CORRIGAN ACCOUNTANTS LIMITED
auditor
-
address
engine shed station approach, bristol, BS1 6QH
Bank
-
Legal Advisor
-
neuronostics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to neuronostics limited.
neuronostics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NEURONOSTICS LIMITED. This can take several minutes, an email will notify you when this has completed.
neuronostics limitedCompanies House Filings - See Documents
